Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if treatment of chronic hepatitis C in people who are on
opiate replacement therapy such as methadone or buprenorphine (including patient who still
inject drugs) is safe and effective.
Phase:
Phase 4
Details
Lead Sponsor:
Melbourne Health
Collaborators:
Hoffmann-La Roche Monash University St Vincent's Hospital, Sydney The University of New South Wales Western Hospital, Australia